Style | Citing Format |
---|---|
MLA | Ebrahimi SM, et al.. "Persianolide-A, an Eudesmanolide-Type Sesquiterpene Lactone From Artemisia Kopetdaghensis, Induces Apoptosis by Regulating Erk Signaling Pathways." Research in Pharmaceutical Sciences, vol. 19, no. 3, 2024, pp. 328-337. |
APA | Ebrahimi SM, Asadi J, Fattahian M, Jafari SM, Ghanadian M (2024). Persianolide-A, an Eudesmanolide-Type Sesquiterpene Lactone From Artemisia Kopetdaghensis, Induces Apoptosis by Regulating Erk Signaling Pathways. Research in Pharmaceutical Sciences, 19(3), 328-337. |
Chicago | Ebrahimi SM, Asadi J, Fattahian M, Jafari SM, Ghanadian M. "Persianolide-A, an Eudesmanolide-Type Sesquiterpene Lactone From Artemisia Kopetdaghensis, Induces Apoptosis by Regulating Erk Signaling Pathways." Research in Pharmaceutical Sciences 19, no. 3 (2024): 328-337. |
Harvard | Ebrahimi SM et al. (2024) 'Persianolide-A, an Eudesmanolide-Type Sesquiterpene Lactone From Artemisia Kopetdaghensis, Induces Apoptosis by Regulating Erk Signaling Pathways', Research in Pharmaceutical Sciences, 19(3), pp. 328-337. |
Vancouver | Ebrahimi SM, Asadi J, Fattahian M, Jafari SM, Ghanadian M. Persianolide-A, an Eudesmanolide-Type Sesquiterpene Lactone From Artemisia Kopetdaghensis, Induces Apoptosis by Regulating Erk Signaling Pathways. Research in Pharmaceutical Sciences. 2024;19(3):328-337. |
BibTex | @article{ author = {Ebrahimi SM and Asadi J and Fattahian M and Jafari SM and Ghanadian M}, title = {Persianolide-A, an Eudesmanolide-Type Sesquiterpene Lactone From Artemisia Kopetdaghensis, Induces Apoptosis by Regulating Erk Signaling Pathways}, journal = {Research in Pharmaceutical Sciences}, volume = {19}, number = {3}, pages = {328-337}, year = {2024} } |
RIS | TY - JOUR AU - Ebrahimi SM AU - Asadi J AU - Fattahian M AU - Jafari SM AU - Ghanadian M TI - Persianolide-A, an Eudesmanolide-Type Sesquiterpene Lactone From Artemisia Kopetdaghensis, Induces Apoptosis by Regulating Erk Signaling Pathways JO - Research in Pharmaceutical Sciences VL - 19 IS - 3 SP - 328 EP - 337 PY - 2024 ER - |